1. 119TiP An observational study to assess the effectiveness and safety of cemiplimab in patients with advanced non-small cell lung cancer (NSCLC) in routine clinical practice within Europe (CEMI-LUNG). (December 2022) Authors: Gessner, C.; Griesinger, F.; Shah, R.; Talbot, T.; Venkateshan, S.; Vadanahalli Shankar, A.K.; Seluzhytsky, A.; Marsden, D.M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗